Detalles de la búsqueda
1.
Reverse metabolomics for the discovery of chemical structures from humans.
Nature
; 626(7998): 419-426, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052229
2.
Reliability and Responsiveness of Histologic Indices for the Assessment of Crohn's Disease Activity.
Clin Gastroenterol Hepatol
; 2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38056798
3.
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
Gastroenterology
; 163(4): 950-964, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788348
4.
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial.
Am J Gastroenterol
; 118(3): 485-490, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36624036
5.
Measuring Serum Vedolizumab and Vedolizumab Antibodies: Comparison of Commercial Assays with the Vedolizumab Clinical Development Assay.
Ther Drug Monit
; 45(2): 236-244, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788448
6.
Endoscopic Assessment of Inflammatory Bowel Disease Activity in Clinical Trials.
Clin Gastroenterol Hepatol
; 20(4): 727-736.e2, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33338657
7.
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis Factor.
Clin Gastroenterol Hepatol
; 20(2): 465-467.e2, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421628
8.
An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
Gastroenterology
; 160(7): 2291-2302, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610533
9.
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.
Dig Dis Sci
; 67(4): 1128-1155, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770330
10.
Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With Infliximab.
Clin Gastroenterol Hepatol
; 19(6): 1209-1217.e2, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376505
11.
Baseline Clearance of Infliximab Is Associated With Requirement for Colectomy in Patients With Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(3): 511-518.e6, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32348905
12.
Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 19(4): 839-841.e2, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147594
13.
Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.
Am J Gastroenterol
; 116(5): 1007-1014, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929379
14.
Similar pharmacokinetics of three dosing regimens comprising two oral delayed-release mesalamine formulations in healthy adult volunteers: Randomised, open-label, parallel-group study.
Br J Clin Pharmacol
; 87(3): 1141-1149, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32671846
15.
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
Dig Dis Sci
; 66(10): 3563-3569, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33089483
16.
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 18(13): 2952-2961.e8, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32062041
17.
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
Am J Gastroenterol
; 115(6): 885-894, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32384283
18.
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.
Gut
; 68(7): 1162-1168, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076171
19.
Infliximab Exposure-Response Relationship and Thresholds Associated With Endoscopic Healing in Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 17(9): 1814-1821.e1, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30613004
20.
Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?
Clin Gastroenterol Hepatol
; 17(13): 2634-2643, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31009791